Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|March 22, 2020
Synthesis, Characterization and Biological Evaluation of Novel Dihydropyranoindoles Improving the Anticancer Effects of HDAC InhibitorsMurat Bingul, Greg M Arndt, Glenn M Marshall, et al.
Bioorganic & Medicinal Chemistry|December 17, 2013
Synthesis and anticancer evaluation of 3-substituted quinolin-4-ones and 2,3-dihydroquinolin-4-onesSantosh Rajput, Christopher R Gardner, Timothy W Failes, et al.
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Characterisation of Novel Tricyclic and Tetracyclic Furoindoles: Biological Evaluation as SAHA Enhancer against Neuroblastoma and Breast Cancer CellsMurat Bingul, Greg M Arndt, Glenn M Marshall, et al.
Biochemical Pharmacology|December 3, 2014
Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screenLeanna Cheung, Denise M T Yu, Zillan Neiron, et al.
BMC Immunology|July 28, 2009
Sequence determinants of innate immune activation by short interfering RNAsAmber Goodchild, Nicole Nopper, Andrew King, et al.
BMC Biotechnology|June 18, 2009
Interfering ribonucleic acids that suppress expression of multiple unrelated genesToby Passioura, Mary M Gozar, Amber Goodchild, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2004
Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?Janette K Burgess, Stephen Carlin, Robert A Pack, et al.
Molecules (Basel, Switzerland)|July 19, 2016
Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline MoietyMurat Bingul, Owen Tan, Christopher R Gardner, et al.
BMC Cancer|October 22, 2009
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancerGreg M Arndt, Lesley Dossey, Lara M Cullen, et al.
Cancer Medicine|August 10, 2022
βIII-tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c-Met positive non-small cell lung cancer cellsSimon Brayford, Alastair Duly, Wee Siang Teo, et al.
Pageof 4